Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203456 · ClinicalTrials.gov registry record · NA
Testing Educational Modalities for Temporomandibular Disorders Curriculum
A NA study of Confidence and Diagnostic Ability, sponsored by Midwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07203456: Recruiting NA study of Confidence and Diagnostic Ability, sponsored by Midwestern University.
NCT07203456 is a NA study of Confidence and Diagnostic Ability that is actively recruiting participants, run by Midwestern University. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203456, a NA study of Confidence and Diagnostic Ability, is actively recruiting participants, sponsored by Midwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is done to assess the change in confidence level, knowledge, and diagnostic ability in TMD-related aspects through the exposure to a Virtual Patient-Based Learning (VPBL) platform featuring temporomandibular disorder (TMD) cases among 3rd and 4th year predoctoral dental students at a larger predoctoral school.
Primary Outcome
Change in confidence level between baseline and after the educational intervention. The self-perceived confidence level will be measured with a 12-item confidence level scale (previously developed and validated by the research group), where answer options range from 0 to 10 on a numerical rating scale (with 0 = "not confident at all" and 10 = "extremely confident"). The 12 items refer to TMD-related skills, including but not limited to providing a treatment plan for patients with TMD, screening
Conditions Studied
Interventions
- OTHER Virtual Patient Based Learning (VPBL)
- OTHER Clinical exposure to patients with TMD
- OTHER Clinical exposure to TMD + VPBL
Study Locations (1)
Illinois
- Midwestern University - Downers Grove
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What NCT07203456 shows while recruiting
NCT07203456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Confidence appearing as the primary indexed condition, and to 3 interventions - of which Virtual Patient Based Learning (VPBL) is the first listed.
NCT07203456 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07203456 about?
NCT07203456 is a clinical study titled "Testing Educational Modalities for Temporomandibular Disorders Curriculum". This study is done to assess the change in confidence level, knowledge, and diagnostic ability in TMD-related aspects through the exposure to a Virtual Patient-Based Learning (VPBL) platform featuring temporomandibular disorder (TMD) cases among 3rd and 4th year predoctoral dental students at a larg...
What is the current status of trial NCT07203456?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-06-13. Estimated completion is 2026-10-01.
What conditions does trial NCT07203456 study?
This clinical trial studies the following conditions: Confidence, Diagnostic Ability.
What interventions are being tested in trial NCT07203456?
The interventions under investigation include: Virtual Patient Based Learning (VPBL) (OTHER), Clinical exposure to patients with TMD (OTHER), Clinical exposure to TMD + VPBL (OTHER).
Who is sponsoring clinical trial NCT07203456?
This trial is sponsored by Midwestern University, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07203456 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07203456's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI